Ferronordic's operations have been severely hit by the sanctions against Russia, as at least two of ...
Aspo actively continues its investigation into strategic alternatives for its operations in Russia, ...
Redeye initiates coverage of ISR Immune System Regulation Holding AB, a Swedish biotech company deve...
Sales still held back by inventory build-up at distributors Weakness to continue in Q2 but potentia...
Q1 operatating EBITA margin of -1.3% (ABGSCe 0.2%) Estimate visibility low on cancellation of guidan...
Redeye comments on yesterday’s announcement regarding the outcome of Annexin’s TO3 warrant program.
Q1’22 EBITDA in line with our expectation We leave ’22e-’23e EBITDA roughly unchanged Maintain SEK 6...
Redeye leaves its comments on Idogen following the report for the first quarter of 2022.
Thinc Jetty redovisade idag en preliminär omsättningssiffra på 84,1 miljoner kronor för första kvart...
Q1 sales -13% vs cons, order intake +17% vs ABGSC The company expect supply chain challenges also in...
Bolagets kampanj över påsk lyckad Omsättningen i Q1 uppgick till 24,5 mkr vs vårt estimat om 21,7 mk...
Redeye comments on Energy Save’s follow-up order from Skanska OY and the new partnership with AQ Gro...
Odramatiskt kvartal men med styrketecken Karolinska Development redovisar ett substansvärde om 1306 ...
Sales in line with better instrument deliveries Strong orderbook but supply and geopolitical uncerta...
Suominen’s Q1 results landed relatively close to estimates, although on the softer side.
Eltel’s Q1 top line was close to estimates, but the war and unforeseen inflation hit bottom line har...
Net sales were 17% above consensus in Q1. Comparable operating profit was even 82% above market (Inf...
Bolagets hyresintäkter är inflationssäkrade, och SBB arbetar med fasta räntor under långa löptider v...
Redeye adjusts the short-term estimates downward due to a slightly more challenging business environ...
Gross profit SEK 8.2m (+3% vs. ABGSCe 8.0m) Expects double-digit growth and increasing gross margin ...
